Functional consequences of sarcomeric protein abnormalities in failing myocardium.
about
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsSarcomeric protein isoform transitions in cardiac muscle: a journey to heart failureRanolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivityThin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.Citrullination of myofilament proteins in heart failure.Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytesLeft ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure.Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.Microsystems for biomechanical measurements.Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2.Maladaptive modifications in myofilament proteins and triggers in the progression to heart failure and sudden death.RBM20, a potential target for treatment of cardiomyopathy via titin isoform switching.Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation.Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.
P2860
Q27000495-C2CAF8BD-9D2A-45DA-9B18-243AC754D0C4Q28252609-27712231-16FD-457E-A0CF-0208BB0BDC53Q28260201-F91E4AD9-0CDC-4CFD-BC70-C87486707CBEQ30582828-9DAE3481-07E8-471E-A3E7-821AE084A6FEQ30670009-1FA331C0-0C39-45B6-BA54-3185E90D5AF6Q33707376-C504FD86-D2FC-40E5-A573-205151FA2056Q34124934-7EA5C529-7924-468A-93FE-74F0CEC922AFQ35395701-B40E3088-E91D-40B9-89BA-C06B11E18E01Q36085051-A0C06663-EBC0-499E-B66C-0F502304F339Q37143953-E36C6F49-1E16-4E5A-BD8F-BBD60E5815C9Q37233904-02E94853-054C-4122-9A44-9039C66793ADQ37257403-778F1BB2-A158-41B1-944B-F483A1364588Q38184402-68FB3FC7-EDC4-474A-A013-A51C9D57EDFCQ38675375-3E83FF40-E931-4091-B593-C9D8E61BF28CQ38950646-1BAF02AA-06CF-4FF5-94C5-49FAA35E2E00Q55066708-282A16D6-DAC2-4179-A2B8-8CFDCD76E4D7
P2860
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@ast
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@en
type
label
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@ast
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@en
prefLabel
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@ast
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@en
P2860
P1476
Functional consequences of sarcomeric protein abnormalities in failing myocardium.
@en
P2093
Martin M LeWinter
P2860
P2888
P304
P356
10.1007/S10741-005-5254-4
P577
2005-09-01T00:00:00Z